# Editorial: Production of novel medical radionuclides and innovative radiopharmaceuticals

**Authors:** Susanta Lahiri

PMC · DOI: 10.3389/fchem.2024.1386045 · Frontiers in Chemistry · 2024-02-27

## Full-text entities

- **Genes:** FOLH1 (folate hydrolase 1) [NCBI Gene 2346] {aka FGCP, FOLH, GCP2, GCPII, NAALAD1, PSM}
- **Diseases:** cancer (MESH:D009369), prostate cancer (MESH:D011471)
- **Chemicals:** Tm (MESH:D013932), 62Cu (MESH:C000615410), Lu (MESH:D008187), 61Cu (MESH:C000615409), tyrosine (MESH:D014443), DOTATOC (MESH:C106246), Ga (MESH:D005708), 64Cu (MESH:C000615411), Sc (MESH:D012538), 60Cu (MESH:C000615408), lanthanide (MESH:D028581), 67Cu (MESH:C000615412), 177Lu (MESH:C000615061), terbium (MESH:D013725), 167Er (-), Cu (MESH:D003300)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10927950/full.md

---
Source: https://tomesphere.com/paper/PMC10927950